Tailor-made Pharma Solutions
Make better informed business decisions with customized pharmaceutical consulting and marketing services that give you the edge over your competition.
Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:
Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.
Biomedtracker, Scrip
Keep up with events as they unfold at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021. Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry.
Pink Sheet
Companies seeking marketing authorizations in the UK or Great Britain will be able to make use of two new “reliance” procedures offering regulatory assessment times of 67 days or less if their products have already gone through the EU centralized or decentralized approval systems.
Topic Brexit Pharma-Brexit
Pink Sheet
There may not be a great deal in the new UK-EU trade and cooperation deal for the life sciences industry but a new working group could act as the forum for constructive discussions on regulatory cooperation.
Topic Regulation Brexit Pharma-Brexit
Medtech Insight
Government and industry in the UK are determined to make the best of the Brexit free trade deal, but German medtechs are eager for trade flow practicalities to be prioritized.
Topic Brexit Medtech-Brexit
In Vivo
The turn of the year is a chance to reflect on times past and the future, to make resolutions and look ahead to changes for the better. With Brexit in mind, this is the time to prophesize on UK medtech’s immediate future.
Pink Sheet
Stay informed of the latest news from the recent US election and understand how the shift in power will affect pharma regulatory and policy issues both within the United States and abroad. Pink Sheet takes you behind the US election headlines for analysis on the real impact you can expect to see on your business.
Topic US Election 2020
In Vivo
Power your strongest strategy for the year ahead with insights from the Outlook 2021 report. A combination of Scrip’s Scrip 100, Medtech Insight’s Medtech 100, and In Vivo’s Outlook reports, Outlook 2021 is a comprehensive window into the key trends, challenges and opportunities impacting the biopharma, medtech, and generics sectors for the year to come.
Topic Outlook
Pink Sheet
Razor-thin majorities in both chambers of Congress mean Democrats can’t enact a bold agenda, and the pandemic and attendant recession mean that the initial legislative focus won’t be on Rx issues.
Scrip
Could Serum Institute or Bharat Biotech be the first company to have a COVID-19 vaccine for children under 12 years of age? While Pfizer and Moderna have begun pediatric trials for children 12 years and above, Serum plans to begin testing its indigenous vaccine and Bharat Biotech its Covaxin in children under 12
Topic Coronavirus
Pink Sheet
The UK regulator, the MHRA, has published guidance on its new integrated pathway for innovative drug approvals, which it says is intended to bring together partners including health technology assessment agencies, health care bodies and patient organizations to offer “sustained collaboration” with drug developers.
Scrip
Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.
Topic Coronavirus
Medtech Insight
The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.
Topic Medtech
Medtech Insight
The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.
Topic Medtech
Medtech Insight
The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.
Topic Medtech
Medtech Insight, Meddevicetracker
Discover what’s on the horizon for spinal devices and technology with news, analysis, and data from Medtech Insight and Meddevicetracker. Keep up with the latest developments from the annual NASS meeting and explore extracts from two data-packed recent reports: Spinal Fusion Implanted Instrumentation and Spinal Motion Preservation Devices Market.
Pink Sheet
27 Jan 2021
Medtech Insight
27 Jan 2021
Pink Sheet
27 Jan 2021
Scrip
27 Jan 2021
Pink Sheet
27 Jan 2021
Generics Bulletin
27 Jan 2021
Generics Bulletin
27 Jan 2021
HBW Insight
27 Jan 2021
Pink Sheet
27 Jan 2021
Scrip
27 Jan 2021
Scrip
27 Jan 2021
HBW Insight
27 Jan 2021
Medtech Insight
27 Jan 2021
Pink Sheet
27 Jan 2021
HBW Insight
27 Jan 2021
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: